Abstract:Graphical and Lay Summary CRISPR/Cas9 technology combined with somatic cell nuclear transfer (SCNT) provides the primary method for producing gene‐edited pigs, with high‐quality gene‐edited nuclear donors closely associated with the forms of CRISPR/Cas9. The authors developed a platform based on fluorescence reporting signals and micropattern arrays to visually assess the efficiency of gene editing. It was efficiently determined that mRNA form targeting porcine cells had the highest editing efficiency. This platform also holds great potential for rapidly testing new gene editing tools, evaluating delivery methods, and customizing assessment platforms for various cell types. CRISPR/Cas9 technology, combined with somatic cell nuclear transplantation (SCNT), represents the primary approach to generating gene‐edited pigs. The inefficiency in acquiring gene‐edited nuclear donors is attributed to low editing and delivery efficiency, both closely linked to the selection of CRISPR/Cas9 forms. However, there is currently no direct method to evaluate the efficiency of CRISPR/Cas9 editing in porcine genomes. A platform based on fluorescence reporting signals and micropattern arrays was developed in this study, to visually assess the efficiency of gene editing. The optimal specifications for culturing porcine cells, determined by the quantity and state of cells grown on micropattern arrays, were a diameter of 200 μm and a spacing of 150 μm. By visualizing the area of fluorescence loss and measuring the gray value of the micropattern arrays, it was quickly determined that the mRNA form targeting porcine cells exhibited the highest editing efficiency compared to DNA and Ribonucleoprotein (RNP) forms of CRISPR/Cas9. Subsequently, four homozygotes of the β4GalNT2 gene knockout were successfully obtained through the mRNA form, laying the groundwork for the subsequent generation of gene‐edited pigs. This platform facilitates a quick, simple, and effective evaluation of gene knockout efficiency. Additionally, it holds significant potential for swiftly testing novel gene editing tools, assessing delivery methods, and tailoring evaluation platforms for various cell types.

CRISPR/Cas9-Mediated Gene Editing in Porcine Models for Medical Research

Genetic Engineering Drives the Breakthrough of Pig Models in Liver Disease Research☆

Progress on Swine Biomedical Model

Application of CRISPR/Cas9 System in Establishing Large Animal Models

[Progress and application of genome-edited pigs in biomedical research]

The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research

CRISPR Technology Acts as a Dual-Purpose Tool in Pig Breeding: Enhancing Both Agricultural Productivity and Biomedical Applications

In vitro genome editing activity of Cas9 in somatic cells after random and transposon-based genomic Cas9 integration

Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine.

Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases

Raav-Crispr/cas9-mediated in Vivo Delivery of Porcine Embryos to Construct Knockout Pigs

Generation of CRISPR/Cas9-mediated Gene-Targeted Pigs Via Somatic Cell Nuclear Transfer

Use of gene-editing technology to introduce targeted modifications in pigs

One-step in Vivo Gene Knock-out in Porcine Embryos Using Recombinant Adeno-Associated Viruses

Porcine germline genome engineering

Visual screening of CRISPR/Cas9 editing efficiency based on micropattern arrays for editing porcine cells

Current Progress of Gene Editing Technique in Modern Porcine Breeding and Animal Model Establishment

Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs

How genome editing changed the world of large animal research

Advances and applications of genetically modified pig models in biomedical and agricultural field.

Gene edited animal models applied in human disease research